The mammalian c-abl gene encodes a nonreceptor tyro sine protein kinase, which is likely to be important in signal transduction pathways during development of lymphoid cells and several other tissues (for recent re views, see Wang 1993; Kerr 1994; Rosenberg 1994) . The gene was originally identified as a homolog of the \-abl oncogene carried by the Abelson murine leukemia virus (A-MuLV; Abelson and Rabstein 1970a,b) , a potent trans forming agent specific for early B lineage cells both in vitro and in vivo (Rosenberg et al. 1975; Alt et al. 1981) . The kinase activity of c-Abl is normally tightly regu lated, and deregulated transforming alleles can be cre ated by various mutations, including deletions at the amino (Franz et al. 1989; Jackson and Baltimore 1989; Muller et al. 1991) or carboxyl terminus (Bergold et al. 1987; Goga et al. 1993) , point mutations (Jackson et al. 1993) , fusion to the retroviral gag gene in v-abl (Goff et al. 1980) , or fusion to the breakpoint cluster region (BCR) locus via t(9:22) translocations that create the Philadel phia chromosome, a diagnostic marker found in 95% of cases of chronic myelogenous leukemia and -10% of acute lymphocytic leukemias in humans (de Klein et al. 1982; Muller et al. 1991; Pendergast et al. 1991) . There is ^Corresponding author. good evidence that in some settings and cells v-abl can promote a G^ -> S transition in the cell cycle (Chen and Rosenberg 1992) , whereas in others v-abl and overex pressed c-abl can inhibit cell growth by causing Gi arrest (Renshaw et al. 1992; Jackson et al. 1993) . The pathways by which Abl induces the transformed phenotype remain unclear, although a large number of known partners have been implicated genetically and biochemically in its ac tivity. Y-abl transformation blocks NF-KB activity in B cells, possibly accounting for its ability to arrest differ entiation Klug et al. 1994) , and dom inant negative mutants of c-myc can block v-aW-medi ated transformation, suggesting that myc lies down stream of abl (Sawyers et al. 1992; Sawyers 1993) . V-Abl can phosphorylate the CTD region of RNA polymerase II in vitro (Baskaran et al. 1993) , and at least some of its downstream effects may thus be mediated by direct modifications to the transcription machinery.
The c-Abl protein contains a number of recognizable motifs that are likely to serve as docking sites for other partners. The protein is often divided into four regions (for review, see Wang 1993 ):
1. Amino-teiminal variable region. Two alternative amino termini for c-Abl proteins, one of which is myristylated, have been identified and shown to arise by the splicing of alternative first exons onto the con served body of the mRNA. 2. Kinase regulatory regions. The region near the amino terminus includes src homologous SH2 and SH3 do mains shared by other tyrosine kinases, PIS kinase, adaptor proteins Grb2, crk, and nek, GTPase activat ing protein (GAP), phospholipase C7, and a number of other proteins (Pawson 1992; Cohen et al. 1995) . The SH2 domain binds phosphotyrosine (Mayer et al. 1991) and is believed to play a role in substrate rec ognition (Koch et al. 1991; Pawson 1992) ; mutations altering the v-Abl SH2 can block its transforming ac tivity or, more specifically, its B-cell-transforming activity (Hevezi et al. 1992) . In contrast, the SH3 domain plays a negative regulatory role in transformation; deletion of the SH3 domain of c-abl can activate its transforming activity for NIH-3T3 cells and permit lymphoma induction in mice (Franz et al. 1989; Jackson and Baltimore 1989) .
Catalytic protein tyrosine kinase or SHI domain.
The kinase domain is the most highly conserved structure across the large PTK family. Tyrosine ki nase activities are essential for Abl-transforming ac tivity, as for many transforming oncogenes {src, fes, erbB, fms], and are assumed to represent essential components of signal transduction pathways that lead to a proliferative response. 4. Noncatalytic carboxy-terminal domain. Unlike many other PTKs, Abl proteins have a unique and large (630 amino acids) proline-rich carboxy-terminal region. This domain is much less conserved and ap pears in only barely recognizable form on the Arg (Abl-related gene product) protein, the closest homolog of Abl (Kruh et al. 1990 ). The carboxy-terminal region is important for efficient lymphocyte transfor mation by v-Abl both in vivo and in vitro but dispens able for transformation of NIH-3T3 fibroblasts Goff et al. 1981b; Watanabe and Witte 1983) . Extensive mutational analysis of this domain and examination of naturally occurring weakly oncogenic viral strains indicate that an intact carboxyl terminus contributes significantly to B-cell tropism Prywes et al. 1983; Hevezi et al. 1992 ), although it is not absolutely required (Parmar et al. 1991) . The carboxyl terminus is also important for normal c-Abl function, as mu tant mice homozygous for a substitution mutation truncating the protein show reduced viability and multiple defects in bone, eye, and lymphoid develop ment (Schwartzberg et al. 1991) , much like those ho mozygous for null mutations (Tybulewicz et al. 1991) . The presence of these many domains in the carboxyl terminus suggests that c-Abl is normally subject to complex regulation and control.
An approach taken in many laboratories toward under standing the mechanisms of action of the Abl kinase has been the identification of proteins that interact with it. Several proteins that bind to the SH2 and SH3 domains of Abl have been identified (Mayer et al. 1991) , including 3BP-1 and 3BP-2 (Cicchetti et al. 1992) , but the function of these proteins is unclear (Mayer and Baltimore 1994) . Recently the carboxy-terminal portion of the retinoblas toma protein, outside of the A/B pocket, has been shown to bind to the kinase (SHI) domain of Abl and inhibit its kinase activity, providing a potential link to its control of the cell cycle (Welch and Wang 1993) . The Abl car boxyl terminus includes the sites for binding to many other proteins. Two distinct regions are recognized by Fand G-actin, accounting for the ability of Bcr-Abl and myristylated forms of c-Abl to associate with F-actin stress fibers in fibroblasts (McWhirter and Wang 1993; Van Etten et al. 1994) . Particularly intriguing is the find ing that Crk and Nek, two SH2-and SH3-containing adapter proteins, bind to Abl in proline-rich sequences immediately downstream of the kinase domain (Ren et al. 1994 ). The Crk-1 protein, first identified as the onco gene on the avian sarcoma virus CTIO, may transform cells through interaction with Abl proteins (Feller et al. 1994; Nichols et al. 1994) . Finally, the carboxy-terminal portion of the Abl proteins have been shown to contain a polylysine nuclear localization signal (NLS) (Van Etten et al. 1989 ) and a closely linked DNA-binding activity that is controlled by phosphorylation in a cell-cycle-de pendent fashion . The role of this binding in Abl function is unclear.
To further our understanding of the mechanisms of action of the Abl proteins, it will be important to iden tify cellular factors that regulate its enzymatic activity, the physiologically relevant substrates of Abl tyrosine kinase, and any other proteins that interact with Abl to form active macromolecular complexes. Because the car boxy-terminal region is unique to the Abl group of PTKs and has important roles in both normal lymphopoiesis and lymphoid cell transformation, cellular proteins that interact with this region may be significant partners and, in particular, may act to control or suppress kinase ac tivity. We have identified and characterized one such protein that binds to Abl. The protein, termed Abl-interactor-1 (Abi-1), was found to be a substrate and a potent suppressor of the transforming activity of the activated v-abl oncogene, strongly suggesting that this protein can interact with Abl proteins to directly modulate its bio logical functions. A closely related human protein, Abi-2, is reported also to act as a substrate of the kinase (Dai and Pendergast, this issue) , suggesting that a conserved family of SH3 proteins may interact with Abl to regulate its activities.
Results

Identification of an Abl-binding protein, Abi-1
To identify cellular proteins that interact with the Abl carboxy-terminal domain, we made use of the yeast two hybrid system (Fields and Song 1989) to screen a library of fusion proteins. A series of plasmid constructs were generated to express different 3' portions of the Abl pro tein fused to the LexA DNA-binding domain. One con struct, pSHAlOOO, expressing the region from the polyl-ysine pentapeptide NLS to the Abl DNA-binding do main, was selected for the stability of the protein and its failure to activate reporter 3-galactosidase (p-gal) expres sion by itself (Fig. 1) . In this region the c-Abl and v-Abl proteins are identical. A library of plasmid DNAs was generated expressing cDNAs from WEHI-3, a murine macrophage cell line, as fusions to the Gal4 activator domain (Dunaief et al. 1993) . Yeast strains containing a suitable lacZ indicator gene downstream from a LexA operator were cotransformed to express pairs of hybrid proteins and screened for colonies expressing p-gal. Of 300,000 yeast colonies screened, a total of six indepen dent clones were recovered that stained blue with X-gal; DNA sequence analysis showed that four different genes were represented among them. The gene with the strong est induction of the indicator, represented twice among the clones, was chosen for further analysis and termed abi-1.
Several controls were carried out to confirm that the p-gal induction was the direct result of the binding of Abl and Abi-1. The plasmid DNA expressing the protein pGAD-Abi-1 was recovered from yeast and tested in combination with various other DNAs for induction of 3-gal ( Table 1 ). The pGAD-Abi-1 DNA scored positive with the LexA-Abl construct, but not with DNA ex pressing LexA alone (pSH2-l). Abl-interactor-1 failed to interact with irrelevant proteins, including the HIV-1 integrase. In addition, it failed to interact with the closest cellular homolog to Abl, the human Arg protein. These results demonstrate that both the Abl probe region and Abi-I were required for LacZ induction. Expression of the Abi-1 sequences as a LexA fusion protein resulted in a direct activation of LacZ expression, suggesting that Abi-1 has inherent transcriptional activation functions when artificially tethered to DNA.
cDNA sequence of Abi-1
Sequence analysis of the abi-1 insert in pGAD-Abi-I, 2.3 kb in length, revealed a single long open reading frame (ORF) fused in-frame to the Gal4 activation domain. To isolate a full-length cDNA, a phage library was screened by hybridization using the abi-1 insert as probe, and a 2.8-kb cDNA was recovered. The sequence of this clone was determined by standard methods (GenBank acces sion no. MMU 17698) and used to predict the protein sequence ( Fig. 2A ). An ATG initiation codon near the 5' end of the insert lay in a good match to the canonical eukaryotic translation initiation consensus, suggesting that this may be the start site for translation of the nor mal mRNA.
The frame is open all the way to the 5' end of the clone, however, and thus we cannot rule out the possibility that additional coding sequences lie farther upstream. The sequence predicts the formation of a pro tein of 394 amino acid residues, with a molecular mass of 42,532 daltons; the protein is basic, with a pi of 10.3. The long 3'-untranslated region of the cDNA contains a polyadenylation signal that is trailed by poly(A).
Comparison among the data base sequences revealed 
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Cold (Renucci et al. 1992 ), 39% and 48%; mouse ^0x3.1 (Breieretal. 1988), 32% and 36%; Drosopiiiia tritiorax (Mazo et al. 1990 ), 35% and 41%; and Drosopiiiifl yan (Lai and Rubin 1992) , 30% and 40%. (D) Alignment of Abi-l SH3 with related SH3 domains in various genes: human growth factor receptor binding protein (Hgrb2, Lowenstein et al. 1992) ; Caenoihabdids elegans sex muscle determining protein (Sem; Clark et al. 1992) ; vav oncoprotein (Vav; Katzav et al. 1989) ; amplexin (Amplx; Schuuring et al. 1993) ; cortactin (Cortct; Miglarese et al. 1994) ; the nek homolog of crk (Nek; Lehmann et al. 1990 ); the ASH linker protein (Ash; Matuoka et al. 1992) ; the second SH3 domains of Hgrb2 (Hgrb22), sem (Sem2), and nek (Nck2); leukemia factor (Leuk; Jackson et al. 1994 ) and the Src oncoprotein (Src; Schwartz et al. 1983) . Identical residues are shaded black; closely related residues are shaded gray. Gaps introduced to improve the alignment are marked by dots.
that the abi-l gene and its protein sequence have signif icant similarity (61% identity at the amino acid level) with a gene identified previously in Xenopus laevis, termed Xlan4 (Reddy et al. 1992) . The gene encodes a maternal mRNA transcript localized in the animal pole region of fully grown oocytes. A zygotic counterpart of the mRNA was detected at highest concentrations in the central nerve system in the adult. The similarity be tween abi-l and Xlan4 extends over the entire ORF, with the exception of the very amino-terminal portion (-80 amino acids) of mouse Abi-l (Fig. 2B ). In addition, Abi-l is very similar (65% identical) to Abi-2, a human protein described by Dai and Pendergast (this issue) . Other evi dence suggests that abi-l and abi-2 are not strict mouse and human homologs of a single gene but, rather, repre sent two members of a family of related genes present in mammals.
The amino-terminal portion of Abi-l is very high in Abl-intetacting piotein serine/threonine content (23%) and exceedingly basic (calculated pi = 11.6). The comparison of the amino-terminal portion of Abi-1 to known protein sequences re vealed a weak homology to several homeo box proteins, especially Hox4.4, HoxS.l, and trithorax ( Fig. 2C ). The homologous region has up to 40% similarity. This region is outside of the homeo box domain and only present in Hox4.4, HoxS.l, and trithorax proteins, but the con served nature may define a signature unique to these three homeotic proteins. The middle portion of Abi-1 contains several promi nent polyproline stretches ( Fig. 2A) . This structure is typical of the transcription activation domains of many transcription factors, homeotic genes, Epstein-Barr virus nuclear proteins, Wilms' tumor protein, the tumor sup pressors p53 and retinoblastoma pi05 (KB), the enhancer binding protein (C/EBP), the mineralocorticoid receptor, and c-myc. The polyproline structures are believed to constitute one class of transcription activation domain. This region may be responsible for the transcriptional activation of Abi-1 detected in yeast when fused to the Gal4 DNA-binding domain. The polyproline structure also includes several copies of the consensus PXXP motif of SH3-binding sites (Ren et al. 1993) , suggesting that this part of Abi-1 may bind SH3 domains, either of Abi-1 itself, c-Abl, or other proteins. The related Abi-2 protein was isolated on the basis of its binding to Abl SH3 (Dai and Pendergast 1995) . Our deletion mutation analysis of this region indicates that it may facilitate Abl-Abi-1 binding (see below). There are also several weak consen sus matches to the PEST sequences, sites that destabilize proteins (Rogers et al. 1986; Salama et al. 1994 ). These sequences suggest that the Abi-1 protein may turn over rapidly.
The very carboxyl terminus of Abi-1 consists of a src homology 3 domain (SH3). The SH3 domain of the prod uct of abi-1 has high similarity to that of Hgrb2 (growth factor receptor-binding protein), vav (oncogene expressed in hematopoietic systems), amplaxin (amplified and overexpressed in breast cancer) and leukemia factor, and only more distant similarity to that of sic and abl (Fig.  2C) . SH3 domains, which are frequently present in pro teins involved in signal transduction pathways, mediate protein-protein interactions by binding to proline-containing sites (Cicchetti et al. 1992; Pawson 1992; Ren et al. 1993 Ren et al. , 1994 .
Binding region of Abl-inteiactor-1
The Abl-binding region of Abi-1 was localized by exam ination of abi-1 mutants with successive amino-terminal [nm series) and carboxy-terminal [cm series) dele tions in the yeast two-hybrid system (Fig. 3) . The plasmids were used to transform yeast cells harboring pSHAlOOO, and the Abl-binding activities of these mu tants were assayed by X-gal staining of colonies. The carboxy-terminal deletions show that the entire 3'-un translated region is dispensable (ratio of blue/white col onies >95%), but that removal of the SH3 domain re sults in complete loss of binding activity (ratio = 0%). Thus, the Abi-1 SH3 domain is essential for the AblAbi-1 interaction. Examination of the amino-terminal deletions suggested that the homeo box homology region was not important (Fig. 3) . Removal of the polyproline domain caused a significant decrease in the LacZ induc tion; mutant Abi-nml, containing a bare SH3 domain, binds Abl only weakly, whereas mutants with both poly proline and SH3 domains bind strongly (mutants Abinm3, Abi-nm4, Abi-nm5; Fig. 3 ). In this setting the role of the polyproline stretches is not to serve as an SH3-binding site, because the Abl probe does not contain an SH3 domain; rather, the polyproline region presumably stabilizes the adjacent SH3 structure. These mapping re sults indicate that the SH3 domain and, to a lesser ex- tent, the polymeric p]X)line structure of Abi-1 are in volved in Abl binding.
Abi-1 expression pattern
The total RNAs from various mouse tissues were ana lyzed for abi-1 expression by Northern blot hybridiza tion. RNA samples were extracted from spleen, thymus, testis, brain, heart, muscle, and kidney of young adult mice, as well as NIH-3T3 fibroblast cultures, and the RNA amounts were normalized using p-actin as refer ence. Abi-1 mRNA could not be detected in most tis sues, and only very low levels were detected in the brain. Two mRNAs, -3.0 and 4.0 kb in size, were observed in the brain (data not shown); the size of the shorter RNA is consistent with the cDNA recovered in pGAD-Abi-1, and the origin and structure of the longer mRNA is un clear. An RNase protection assay with a labeled antisense probe was used to test for mRNAs with greater sensitivity. Although the highest level was again found in the brain, abi-1 mRNA was also detected in testis, bone marrow, spleen, and the myelomonocytic cell line WEHI-3 from which the clone was originally obtained (Fig. 4) . Very low levels were found in liver, kidney, and lung, and none could be detected in heart, thymus, mus cle, and NIH-3T3 cells. These results suggest that abi-1 is expressed fairly widely, albeit at low levels. The ex pression in spleen and bone marrow, and not in thymus, is intriguing and suggests selectivity for B lineage cells, site of A-MuLV-specific tropism for transformation.
abi-1 is closely linked to Abl in the mouse genome
The map position in the mouse genome of a cloned DNA can be readily determined by testing for linkage with polymorphisms among closely related interfertile mu rine species. We used DNAs from a {C57B1/6JxMus spretus] F^xM. spretus (ESS type) backcross panel to deter mine the map position of abi-1. PCR primers lying in the 3'-untranslated portion of the cDNA were used to am plify a 700-bp DNA fragment from the genomic DNAs of the parental strains. Although the sizes of the amplified DNAs from the two stains were indistinguishable, diges tion with Ddel generated four products, with a restric tion fragment length polymorphism (RFLP) in the small est ones (60-bp doublet in M. musculus vs. 75 and 60 bp in M. spretus). The alleles were then characterized in each of 94 DNA samples in the backcross panel obtained from the Jackson Laboratory (Bar Harbor, ME; Rowe et al. 1994) . Haplotype analysis from these mapping data indicated that the abi-1 locus is positioned between Jund2 and D2Bir5 (Birkenmeirer anonymous DNA frag ment 5) markers on mouse chromosome 2 (Fig. 5A) . One of the most closely linked biological markers is c-abl, ~5 cM telomeric to abi-1 (Fig. 5B) . As predicted by synteny, the map position of abi-1 corresponds to human chro mosome 9q32-34; the locus in humans would be telom eric to c-abl. Thus, the t(9:22) translocations forming the Philadelphia chromosome would result in the cotranslocation of abi-1 with c-abl to chromosome 22.
Binding and phosphorylation of Abi-1 by Abl proteins in vitro
To determine whether the activation in yeast reflected a direct interaction between the Abl and Abi-1 proteins, in vitro binding experiments were performed. The Abi-1 sequence was inserted into an expression vector to direct the synthesis of a recombinant glutathione S-transferase (GST) fusion protein in bacteria. The GST-Abi-1 fusion was purified from bacterial lysates by binding to gluta thione-agarose beads. The beads containing the isolated protein were incubated with cell extracts prepared from cells transformed by A-MuLV strains PI60 (encoding pj^Qv-flWj Qj. g^j.^-jj p9Q^ (encoding the shorter p90^"''''^ protein), or from untransformed NIH-3T3 cells, and then washed extensively with the binding buffer. The bound materials were eluted, resolved by electrophoresis on SDS-polyacrylamide gels, and immunoblotted with anti-Abl antibodies. Although the control GST protein alone did not bind any proteins reactive to anti-Abl an tibodies, GST-Abi-1 bound high levels of pl60''"''^^ in A-MuLV-transformed cells (Fig. 6A) . In contrast, GSTAbi-1 did not bind the closely related v-Abl-transforming protein of the P90A strain, p90^"''^^ (Fig. 6B) . The lack of interaction with p90'^'''^^, a naturally occurring mutant lacking most of the carboxy-terminal portion of pl60''"''''^ or plSO'^-^^^ ( Fig. 1 ; Goff et al. 1981b; Murtagh et al. 1986) , is consistent with the requirement for the Abl carboxyl terminus for binding in yeast. In these experi ments, the levels of v-Abl proteins swamp out c-Abl and preclude its detection. To test for interaction with c-Abl, lysates from uninfected NIH-3T3 cells were exposed to GST-Abi-I beads. Even though the plSO^"''^^ protein is present at very low levels as compared with v-Abl pro teins, binding could be observed (Fig. 6C) . The largest band detected with the anti-Abl antibody, migrating at 150 kD, comigrates with c-Abl; low molecular mass bands detected in these experiments are degradation products of c-Abl and other proteins detected by this antibody, apparent only after the long development times required for c-Abl detection. These results suggest that both full-length v-Abl and c-Abl proteins are in a suitable conformation to bind to Abi-1. The interaction of Abi-1 and Abl was independent of divalent ions such as Mg^"^ and Ca^"^, neither the addition of 20 mM Mg^"^ and Ca^"^, nor addition of EDTA and EGTA, had any effect on the binding activity.
To test whether bound Abi-1 could serve as a substrate for the v-Abl kinase after binding in vitro, beads contain ing various protein complexes were incubated with [7-^^P]ATP and the products were then analyzed by elec trophoresis and autoradiography. Beads containing GSTAbi-1 and complexed with the PI60"'"^^ kinase showed strong phosphorylation of the GST-Abi-1 protein, sug gesting that bound Abi-1 was a substrate (Fig. 6D) . Trace autophosphorylation of the pi60'^"''^^ could also be de tected. The amount of label detected in the experiments was very high as compared with phosphorylation of other proteins by similar amounts of v-Abl, including autophosphorylation of v-Abl. Beads containing GSTAbi-1 and exposed to buffer alone, or lysates of NIH-3T3 cells or P90A-transformed NIH-3T3 cells did not show phosphorylation of Abi-1. Beads containing GST alone bound no detectable kinase activity. These results dem onstrate that Abi-1 bound to v-Abl in vitro was properly positioned to serve as a substrate for the kinase. Addi tional experiments, in which purified GST-Abi-1 pro tein was added to immunoprecipitated pi60^""'*'^, did not show any inhibition of overall autokinase activity (data not shown). These results suggest that Abi-1 is not a direct inhibitor of the v-Abl kinase activity per se.
Abi-1 suppresses v-Abl-transfoiming activity
To determine the effect of Abi-1 on the transforming activity of v-Abl oncoproteins, we measured the focusforming activities of Abelson leukemia viruses on NIH-3T3 cell lines induced to overexpress Abi-1 protein. The Abi-1 sequence was inserted downstream of the cyto megalovirus (CMV) early promoter to form plasmid pCGN-Abi-1, and NIH-3T3 cell lines were cotransformed with a mixture of this expression plasmid and the pWLneo plasmid encoding neomycin resistance. G418 resistant clones (G418'') were picked, expanded, and tested for expression of Abi-1 protein by immunoblotting proteins in extracts using an Abi-1-specific an tiserum (Fig. 7A) . Of 14 randomly picked clones, 3 were found to overexpress Abi-1 (G418'^/Abi"^); this efficiency of cotransformation for unlinked DNAs is typical and does not suggest significant toxicity for the gene. No detectable alterations of cell morphology, doubling time, or contact inhibition upon reaching confluence were seen in the Abi-1-overexpressing cells. The expressing and nonexpressing clones were all analyzed in parallel to provide controls. Virus preparations of two strains of Abelson leukemia viruses PI60 and p90A that encode pi60^-''^^ and p90''"''^^ oncoproteins, respectively, were tested for their trans forming activities in those cell lines. NIH-3T3 cell control in a standard focus-forming assay. Infected cultures were allowed to grow to confluence, and transformed foci were counted after 12 days (Fig. 7B ). The P160 virus typically exhibited titers of 10"^ FFU/ml on NIH-3T3 cells and G4187Abi-1" cells. The three 0148""/Abi-1 "^ cell lines, however, showed strong inhibition of transformation activity, producing significantly fewer foci: 10-to 100-fold fewer than the parental NIH-3T3 cells or the control G418VAbi-1" cells. The perfect correlation of Abi-1 overexpression with the greatly reduced focus-forming activity strongly suggests the involvement of Abi-1 in the transforming activity of the PI60 strain. In contrast, there was no significant change of the P90A strain's focus-forming activity in the 0418^"/ Abi-1 "^ cell lines (Fig. 7C) . Thus, the suppression of transformation by abi-1 requires the carboxy-terminal portion of the v-Abl protein. The overexpression of abi-1 did not block the general ability of t h e cells to become transformed by all v-Abl proteins, suggesting that the loss of pi60^'"^^^-transforming activity did not result from the loss of a fundamental signal response pathway. The observed loss of transforming activity in G418V Abi-"^ cell lines could, in principle, be accounted for by a block to virus replication. To test whether the cells were infected with virus, supernatant culture medium from the G418^ and G418' /Abi-1 ^ cell lines after infection with the PI60 virus were collected. The level of helper virus was assessed by measuring the reverse transcriptase (RT) enzyme activity in the supernatant. RT activities from the G4187Abi-1 ~ or G4187Abi-1 •" cells did not reveal any decrease in viral replication compared with that of the parental cell line (data not shown). Thus, we can attribute the reduced PI60 viral-transforming activity in G418''/Abi-1'^ cells to the specific suppression of pi60^"''^^ function instead of decreased viral replication. In principle, the lack of transformed cells could be attributable to genuine transformation resistance or to inappropriate cell death upon infection; the latter possibility is not implausible, given that v-abl expression can be toxic in some settings (Zeigler et al. 1981) . To test whether the A-MuLV genome was successfully integrated, expressed, and maintained in the lines, viral supernatants were collected and the focus-forming titers present in these supernatants were determined by infection of fresh NIH-3T3 cells. The Abelson viruses produced by the G418''/Abi-1 "^ cell lines retained full transforming potency; no significant difference in titer was found in comparing virus released from the parental N1H-3T3 cells or from the G4187Abi-1" cells (range 1x10^ to 5x10^ FFU/ml; data not shown). Therefore, Abi-1 did not in some way alter the PI60 virus or the Y-abl gene, block production of A-MuLV RNA or release of virion particles, or sensitize the cells to w-abl toxicity.
The effect of Abi-1 on NIH-3T3 cell transformation by Y-src was also assessed. Src and Abl belong to the same protein tyrosine kinase family and share substantial similarity in their SH2, SH3, and kinase catalytic domains. Both w-src and y-abl transform NIH-3T3 cells, although subtle morphological differences are apparent between their transformed cells and foci. A virus carrying the y-src oncogene (Hevezi et al. 1993) , using Mo-MuLV as helper, was similarly titered on the G418''/Abi-1"^ and G418''/Abi-1"^ cell lines for its focus-forming activity. No appreciable difference in the v-src-transforming activity was observed in Abi-1"^ versus Abi-1 ~ cells (Fig.  7D) . Thus, Abi-1 did not act on unrelated tyrosine ki- 
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Coimmunopiecipitation of Abi-1 and v-Abl proteins
To determine whether Abi-1 protein was associated with Abl proteins in vivo, attempts were made to coimmunoprecipitate a complex from cell lysates. Cells expressing both proteins were generated by acute infection of the Abi-1-positive clone A7 cells with either the PI60 or P90A strain of A-MuLV. At 48 hr postinfection, lysates were prepared and the Abi-1 protein was immunoprecipitated with a polyclonal anti-Abi-1 antiserum raised against GST-Abi-1 in rabbits. The proteins were col-lected on protein A-agarose beads, and the bound pro teins were eluted, separated by SDS-PAGE, and blotted to nitrocellulose. The blots were then probed with antiAbl monoclonal antibodies. As a control the v-Abl pro teins were also directly immunoprecipitated with antiAbl sera and analyzed on the same blots. The results showed that the anti-Abi-1 antiserum, but not preimmune serum, efficiently coprecipitated the pi60"^"''''^ pro tein (Fig. 8) , nearly as well as the anti-Abl antibody. In contrast, the anti-Abi-1 antiserum did not bring down the truncated ^90"""^^ protein (Fig. 8) . Thus, the majority of the v-Abl protein of the PI60 strain is present in com plex with Abi-1. The formation of the complex corre lated with the presence of the carboxy-terminal se quences of v-Abl, and with the specific suppression of v-Abl-transforming activity by Abi-1, suggesting that the activity was mediated by direct binding of the two pro teins in vivo.
Discussion
The carboxy-terminal domain of Abl has been of partic ular interest as a unique structure of the tyrosine ki nases. This structure may have roles in the specific func tions associated with Abl proteins: tropism for transfor mation of pre-B lymphoid cells Parmar et al. 1991) , cytotoxicity in cultured cells (Zeigler et al. 1981) , and the various phenotypes dis played by c-Abl carboxy-terminal domain knockout mice (Schwartzberg et al. 1991) . The carboxy-terminal region may thus help to specify the various targets of the Abl kinase. The ability of Abi-1 to bind specifically to this part of Abl proteins and block v-Abl transformation suggests that it plays a negative role in Abl kinase func tion or target selection. Abi-1, however, does not seem to inhibit the overall kinase activity of v-Abl. The simplest model for the mode of action of Abi-1, when highly overexpressed, is as an inhibitor of the kinase's ability to bind to other critical targets. Abi-1 binding could act by com petition to interfere with the localization, folding, or binding of the kinase to such targets. The fact that the inhibitory activity absolutely requires the carboxy-ter minal interaction domain of v-Abl strongly suggests that the mechanism occurs via the direct binding to v-Abl rather than through some downstream step in the path way. The fact that deletions of the carboxyl terminus of v-Abl can enhance the transforming activity of viral vari ants is consistent with a neg ative role for Abi-1 binding to this region in the wildtype protein. Abi-1 bound to both v-Abl and c-Abl in vitro (Fig. 6) , and it may play a role in signaling for both proteins. The functions of c-Abl remain unclear, how ever, and a determination of Abi-Ts functional relation ship with c-Abl must await new readouts of its activi ties. It should be emphasized that suppression activity was only observed in a setting of Abi-1 overexpression and that at lower concentrations the normal functions of Abi-1 could serve either as a negative or positive regula tor of Abl function. The reduction in the number of foci seen with the PI60 strain of A-MuLV, as opposed to the complete elim ination of foci, may reflect the relative level of expres sion of Y-abl and abi-1. Individual clones of cells infected by A-MuLV exhibit a wide range of levels of expression of the viral oncoprotein, presumably reflecting position effects of the different integration sites of the proviral DNA. If a threshold level of Abi-1 protein is required to block transformation, a few clones would be generated by infection that would express high enough levels of v-Abl to overcome the block. Such clones could account for the residual transformants.
The product of the newly identified gene abi-1 joins a large number of SH3-containing proteins, including most prominently the tyrosine kinases (such as Src, Abl, and receptor kinases) and the adaptor proteins (such as Grb2, Sos, and Crk), that may play roles in signal trans duction (Koch et al. 1991; Pawson 1992; Cohen et al. 1995) . The proteins binding to Abl at the most similar position as Abi-1 are the products of the cik oncogene and its relative nek (Ren et al. 1994) . Although the bind ing sites for these proteins are not identical to that for Abi-1 (Fig. 1) , they are close enough in the primary se quence that Abi-1 might well interfere with their bind ing or compete with them for access to Abl. SH3 do mains are thought to mediate the binding of the various signal transduction proteins to polyproline motifs on a variety of target proteins (Ren et al. 1993) . Abi-1 and its family members may thus be bound to polyproline stretches on a number of such other targets. However, it should be noted that Abi-1 also includes a polyproline stretch of its own, and, in particular, proline motifs com mon to SH3-binding sites. Its SH3 domain may thus bind intramolecularly to its own proline-rich region or might promote head-to-tail homodimerization with another Abi-1 molecule. Furthermore, the proline region may bind to other SH3 domains. The proline-rich region of the closely related Abi-2 protein binds specifically to the SH3 domain of c-Abl (Dai and Pendergast, this issue) . Abi-1 does not contain any SH2 motifs, and it is not clear whether it serves to bridge Abl to any other proteins.
The homeo box similarity in the central portion of the molecule may indicate that Abi-1 is bound to DNA, but direct DNA-binding activity has not been observed. The most similar gene in the data base is xlan4, a gene of Xenopus expressed as a maternal mRNA accumulated in the oocyte (Reddy et al. 1992) . A zygotic cognate of that mRNA is also expressed during the formation of the de veloping central nerve system; in situ hybridization sug gests that the gene is expressed in the forebrain, mid brain, hindbrain, and spinal cord. Although it is intrigu ing that Abi-1 is also expressed in the brain, there is no evidence of a function for c-Abl in neural development. The similarity to a human gene, Abi-2, whose product also binds to Abl proteins as described in Dai and Pendergast (this issue) , suggests that the gene and the inter action are both conserved among mammals. The rather limited sequence similarity between these two genes (for mouse vs. human) suggests that they are not strict homologs but simply related members of a multigene fam ily present in both mouse and humans.
The abi-1 gene maps to mouse chromosome 2 near c-abl. It is unclear whether this linkage reflects any fimctional relationship. Based on synteny, this corresponds to human chromosome 9q32-34, telomeric to human c-abl. Thus, the abi-1 gene is likely cotranslocated with human chromosome 22 during the formation of the Phil adelphia chromosome. Given the abi-1 transformationsuppressing activity and its proximity to the major cy togenetic alteration, it is possible that abi-1-or perhaps its loss of expression-plays a role in the pathogenesis in chronic myelogenous leukemia (CML). By examining abi-1 expression levels or other changes in Ph"^ leuke mia cell lines or patients, a correlation may be obtained for the prediction of the progression or the prognosis of leukemia. There have been reports that homeotic genes may be involved in certain types of cancers. For example, deletions spanning the Hox4.1 locus were found in a ma jority cases of a panel of mouse myeloid leukemias (Blatt and Sachs 1988) ; and translocations involving MLL, a mammalian gene with similarity to the Drosophila trithorax gene, are frequently founds in several acute lymphoblastic and myeloid leukemias in humans (Row ley 1993).
The fact that the Abi-1 protein can act genetically as a tumor suppressor with specificity for the Abl protein suggests that overexpression of the protein could in prin ciple serve to block tumor formation or progression in CML patients bearing the Philadelphia chromosome. Thus, constructs overexpressing the protein might find therapeutic applications. Successful uses await technol ogy for efficient gene transfer of expression constructs into tumor cells and tissues. The identification of abi-1 as a modifier of abl function may provide new insights into the mechanisms by which c-Abl kinase transmits signals to control target gene expression, and by which v-Abl mishandles that process.
Materials and methods
Yeast two-hybrid system for identifying interacting proteins
cDNA library from the murine myeloid cell line WEHI-3 (Stratagene) was transferred into the yeast expression vector pGAD-NOT, and clones were collected in pools of 100,000 each (Luban et al. 1992; Dunaief et al. 1993) . A fragment of the coding region of the v-Abl carboxy-terminal domain (nucleotides 3237-4366; Hevezi et al. 1992 ) was inserted into yeast expression vector pSH2-l (Hanes and Brent 1989) to form pSHAlOOO, encoding a LexA DNA-binding Abl hybrid. Hybrid protein expression from this construct was verified by Western blot with anti-Abl anti body. Plasmids were used to transform yeast strain CTY10-5d (gift of R. Sternglanz, State University of New York, Stony Brook) by the LiAc-PEG method as described previously (Ausubel et al. 1987) . Double transformants were plated on Leu~His~ selection plates and tested for interacting two-hybrid clones by staining nitrocellulose replicate lifts with X-gal as described previously (Kalpana et al. 1994) .
DNA cloning, sequencing, and data analysis
DNA manipulations were by standard methods (Maniatis et al. 1982) . DNA sequencing was performed with plasmid templates on an automated BioSequencer (Applied Biosystems). The se quence data were analyzed by BLAST comparisons (National Library of Medicine) or GCG sequence analysis software pack age version 7 (Genetics Computer Group, Inc.).
Deletion mutagenesis and binding domain mapping
Unidirectional deletions were introduced into the abi-1 cDNA on plasmid pGADNOT by nested exonuclease III/SI treatment at room temperature according to specifications of the manu facturer (Promega). Clones were picked after transformation of the mutagenized DNAs derived from various times of exonu clease treatment. Clones were sequenced and tested for their interaction with Abl protein in the yeast two-hybrid system.
Expression and purification of recombinant GST-fusion proteins
Recombinant GST-fusion proteins were produced by plasmids based on pGEX2TK (Pharmacia). The production and purifica tion of the fusion proteins followed the manufacturer's specifi cations. Briefly, Escherichia coli cells harboring the plasmid in mid-log phase were induced with 1 mM IPTG. The cells were disrupted by freeze-thaw and sonication in the presence of 1 mM PMSF. The GST-fusion protein was affinity purified by glutathione-agarose beads (Sigma) from a clarified cell lysate. The amount and homogeneity of the products were analyzed by electrophoresis on SDS-polyacrylamide gels stained by Coomassie blue R250.
Binding and phosphorylation of GST-Abi-1 by v-Abl proteins in vitro
Cell extracts were prepared from NIH-3T3 cells, or cell lines transformed by either PI60 or P90A strains of A-MuLV. Cells were washed gently three times with chilled PBS supplemented with 50 mM glucose. The cells were then resuspended in TNEN buffer (50 mM Tris-HCl at pH 7.5, 50 mM NaCl, 2 mM EDTA, 0.5% NP-40, 1 mM PMSF, 2 M-g/ml each of pepstatin, leupeptin, and aprotinin) at ~10^ cells/ml and lysed by sonication. The lysate was clarified by centrifugation at 10,000g. The total pro tein concentration was typically 5 mg/ml. In standard Abl-Abi-1-binding assays, 400 |xl of cell extract was agitated gently on ice for 15 min with 10 |xl glutathione-agarose slurry charged with GST-Abi-1 fusion protein. The unbound fraction was removed by washing the beads with the TNEN buffer. The bound mate rials were resolved by SDS-PAGE and immunoblotted with spe cific antibodies. To monitor kinase activity, the beads and their bound proteins were washed as described previously and added to 100 |xl of kinase buffer (50 mM Tris-HCl at pH 8.0, 50 mM NaCl, 6 mM MnCl2, 1 mM CTP, 0.2 mM NagVOa, 1 mM PMSF, 2 |JLg/ml each of pepstatin, leupeptin, and aprotinin). The reac tion was initiated by addition of 20 jJiCi of [7-^^PlATP (5000 Ci/mmole), allowed to proceed for 30 min at room temperature, and terminated by repeated washing of the beads with kinase buffer. The bound proteins were eluted by boiling in 40 [d of sample buffer for 2 min, and 1 | JL1 of the eluate was analyzed by electrophoresis on 12% polyacrylamide gels followed by auto radiography.
Coimmunoprecipitation of Abi-1 and Abl proteins
The A7 clone of NIH-3T3 cells expressing Abi-1 protein was infected with the PI60 or P90A strain of A-MuLV by coculture with appropriate virus-producing cell lines; -5x10^ cells of each line were mixed and plated together with a 2.5x dilution. After 48 hr, the cultures were lysed with 2 ml of TNEN buffer, and the lysate was clarified by centrifugation. Lysate (400 \xl) was incubated with anti-Abi-1 antiserum for 1 hr, and the immunocomplexes were collected on protein A-agarose beads. The bound material was eluted in sample buffer and analyzed by electrophoresis on a 10% polyacrylamide gel. The proteins were visualized after blotting to nitrocellulose by probing with antic-Abl monoclonal antibodies 24-11 or K12 (Santa Cruz Biotech nologies). Polyclonal anti-Abi-1 antisera were raised by immu nization of rabbits with 100 |xg of purified GST-Abi-1 protein in complete Freund's adjuvant, with boosts of similar amounts of protein in incomplete adjuvant.
fected by the calcium phosphate precipitation method (Chen and Okayama 1987) . Plasmid pWLneo provided a neomycin se lection marker (Stratagene). abi-1 expression in G418-resistant clones was determined by immunoblot analysis of whole-cell extracts with anti-Abi-1 antibody. Antisera were prepared in rabbits by immunization with recombinant GST-Abi-1 protein.
A-MuLV focus-foiming assay
PI60 and P90A A-MuLV virus stocks were prepared by rescuing virus from transformed nonproducer NIH-3T3 cells with MoMuLV helper virus. To measure susceptibility to infection, cells were exposed to the virus stocks at 1:10 serial dilutions as de scribed (Scher and Siegler 1975) . The monolayers were then maintained in Dulbecco's modified Eagle medium supple mented with 5% bovine calf serum. The foci were scored after 2 weeks of incubation.
RT assay
The retroviruses released to the culture media were harvested and passed through 0.45-|xm filters (Nalgene). The incorpora tion of [^^PjTTP into DNA on a poly(rA)/oligo(dT) substrate was assayed by standard methods (Goff et al. 1981a ).
Abl tyrosine kinase assay
pj^gQv-aw protein was collected from a cell lysate (500 \xl) pre pared from P160-transformed cells by anti-Abl antibody immo bilized on protein A-agarose. The immobilized pi60^"^^ was added to GST-Abi-1 (total protein concentration 1 mg/ml; 100 |xl) in kinase buffer (50 mM Tris-HCl at pH 8.0, 50 mM NaCl, 6 mM MnClj, 1 mM CTP, 1 mM PMSF, 2 |xg/ml each of pepstatin, leupeptin, and aprotinin) and preincubated for 15 min. The ki nase reaction was initiated by adding [^-^^PjATP (5000 Ci/ mmole) to a final concentration of 20 nM and allowed to proceed at 24°C for 15 min. The reaction was terminated by addition of ATP and EDTA to final concentrations of 10 mM each. The labeled proteins were resolved by SDS-PAGE and detected by autoradiography.
Analysis of abi-1 mRNA levels
The tissue distribution of abi-1 mRNA was determined by RNase protection assays. An antisense RNA probe was prepared by in vitro transcription reactions using T3 RNA polymerase on a linearized Bluescript pSKII plasmid containing a 362-bp frag ment of abi-1 cDNA (nucleotides 884-522), according to the specifications of the manufacturer (Stratagene). The RNA probe was purified by electrophoresis on a 5% polyacrylamide/urea gel. Whole-cell RNA was prepared from 100 mg each of liver, lung, heart, brain, thymus, spleen, kidney, muscle, testis, and bone marrow of young adult mouse, and from NIH-3T3 cells and WEHI-3 cells, using the RNAzol B RNA isolation method (TEL-TEST). The amount of RNA in each sample was deter mined by OD260 and by ethidium bromide staining of agarose gels. RNA (15 |i,g) from each sample was used to protect the probe from RNase A plus Tl digestion for the RPA II ribonuclease protection assay (Ambion). The digestion products were resolved on a 5% polyacrylamide/urea gel and detected by au toradiography.
Overexpression of Abl-interactor-1 in NIH-3T3 cells
The abi-1 cDNA was inserted in-frame into the pCGN expres sion vector (Tanaka and Herr 1990) . NIH-3T3 cells were transMapping of the abi-1 gene in the mouse genome Two oligonucleotides (5'-GGAGGCAGTTCCAAACATTG-3') and (5'-GGACACATTAAGATTAAGC-3') from the abi-1 3'-untranslated region were used as DNA polymerase chain reac tion primer pairs to amplify mouse genomic DNA from M. spretus and M. musculus (The Jackson Laboratory). The PCR prod ucts from each animal were digested with restriction enzymes. One Ddel RFLP was found. The panel of DNAs from 94 M. spretus and M. musculus interspecific backcross (BSS type) an imals was then analyzed for the haplotypes based on the RFLP (Rowe et al. 1994) .
